Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Rodriguez, F. Andreo, J. Sanz, E. Monsó, L. Setó, J. Sauleda, F. De Borja, A. Noguera, A. Rosell (Vilafranca del Penedès, Badalona, Palma de Mallorca, Spain). Systemic inflamation and bronchial dysplasia in risk lung cancer subjects. Eur Respir J 2009; 34: Suppl. 53, 2669

Member's Comments

No comment yet.

Related content which might interest you: COPD as an independent risk factor for lung cancer in patients with bronchial squamous dysplasia Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Angiogenesis in bronchial biopsies of symptomatic smokers with and without lung cancer Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort Source: Eur Respir J, 49 (5) 1601162; 10.1183/13993003.01162-2016 Year: 2017 Investigation of biomarkers for pulmonary carcinomatous lymphangitis in patients with lung cancer Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Pecularities of lung cancer in patients with COPD Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 Coexistence of COPD in lung cancer patients Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001 Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 Incidence of lung cancer among COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 494s Year: 2005 Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing Source: Eur Respir J 2004; 24: 502-505 Year: 2004 Chronic obstructive pulmonary disease is an independent risk factor for nonsmall cell lung cancer in smokers Source: Eur Respir J 2002; 20: Suppl. 38, 254s Year: 2002 Emphysema, airway obstruction and prognosis in lung cancer Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Systemic inflammation and pulmonary hypertension in patients with bronchial asthma Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 The Asian experience in co-existing lung cancer and interstitial lung disease Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018 Clubbing in patients with fibrotic interstitial lung diseases Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Bilateral lung cancer with COPD or metastatic disease Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology Year: 2016 Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Management of concomitant COPD in patients with lung cancer Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Prevalence of bronchiectasis in a lung cancer screnning program Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019